Replies to post #187597 on Biotech Values

[DewDiligence]

I haven’t made any decision yet on the new RGDO (i.e. Tobira). Will probably wait for the reverse merger to close before taking any action.

Do you see this new entity as a potential NASH play?

Yes, they will be a player, but NASH is a tough playground.